"Demyelinating Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Descriptor ID |
D003711
|
| MeSH Number(s) |
C10.314
|
| Concept/Terms |
Demyelinating Diseases- Demyelinating Diseases
- Demyelinating Disease
- Demyelinating Disorders
- Demyelinating Disorder
|
Below are MeSH descriptors whose meaning is more general than "Demyelinating Diseases".
Below are MeSH descriptors whose meaning is more specific than "Demyelinating Diseases".
This graph shows the total number of publications written about "Demyelinating Diseases" by people in this website by year, and whether "Demyelinating Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1993 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 4 | 0 | 4 |
| 2009 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Demyelinating Diseases" by people in Profiles.
-
Blauth K, Zhang X, Chopra M, Rogan S, Markovic-Plese S. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis. Clin Immunol. 2015 Apr; 157(2):121-32.
-
Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol. 2009 Mar; 65(3):286-93.
-
Lindzen E, Jewells V, Bouldin T, Speer D, Royal W, Markovic-Plese S. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J Neurovirol. 2008 Nov; 14(6):569-73.
-
Shindler KS, Kenyon LC, Dutt M, Hingley ST, Das Sarma J. Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus. J Virol. 2008 Sep; 82(17):8882-6.
-
Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res. 2008 Sep; 87(3):208-13.
-
Iocca HA, Plant SR, Wang Y, Runkel L, O'Connor BP, Lundsmith ET, Hahm K, van Deventer HW, Burkly LC, Ting JP. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. J Neuroimmunol. 2008 Feb; 194(1-2):97-106.
-
Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res. 2007 Apr; 85(5):967-76.
-
Sair HI, Mohamed FB, Patel S, Kanamalla US, Hershey B, Hakma Z, Faro SH. Diffusion tensor imaging and fiber-tracking in Marchiafava-Bignami disease. J Neuroimaging. 2006 Jul; 16(3):281-5.
-
Lindzen E, Gilani A, Markovic-Plese S, Mann D. Acute disseminated encephalomyelitis after liver transplantation. Arch Neurol. 2005 Apr; 62(4):650-2.
-
Renaud S, Hays AP, Brannagan TH, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 2005 Feb; 159(1-2):203-14.